Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,258,047
+$433,547 QoQ
Shares Held
8,891
+19.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#2,249
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Focused Wealth Management, Inc holds $11,871,008 across 7 Drug Manufacturers - General names. JNJ ranks #4 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
119,833 | $2,885,578 | |
| 2 | LLY |
ELI LILLY & Co
|
2,178 | $2,612,358 | |
| 3 | ABBV |
AbbVie Inc.
|
9,724 | $2,446,947 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
8,891 | $2,258,047 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,826 | $1,005,641 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,585 | $437,047 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,784 | $225,390 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,258,047 | 8,891 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,824,500 | 7,464 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,438,302 | 6,950 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,275,504 | 6,879 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $1,047,254 | 6,856 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,661,385 | 10,018 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,428,411 | 9,877 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,629,837 | 10,057 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,489,224 | 10,189 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,682,667 | 10,637 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,682,760 | 10,736 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,687,707 | 10,836 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $1,779,671 | 10,752 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,789,010 | 11,542 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $2,021,405 | 11,443 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,883,540 | 11,530 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,046,335 | 11,528 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,997,204 | 11,269 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $1,703,343 | 9,957 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $1,605,956 | 9,944 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $1,655,801 | 10,051 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,642,842 | 9,996 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,562,153 | 9,926 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,594,802 | 10,712 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $1,428,941 | 10,161 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $917,254 | 6,995 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||